- Angelica archangelica L., Apiaceae. Source: root; steam distillation. "Angelica Root / European Angelica / Garden Angelica / Bạch chỉ Âu". Flagship furanocoumarin-phototoxic non-citrus oil + flagship CYP3A4 mechanism-based inhibitor EO (grapefruit-juice-mechanism class). Distinct from [[angelica-root-himalayan]] (A. glauca, phthalide-dominant, different hazard profile) + angelica SEED (same species, different part, MUCH lower phototoxicity).
- Chemistry (Kerrola 1994; Chalchat 1991 — via B216): α-Pinene 14.0–31.1% + δ-3-Carene 8.0–13.8% + α-Phellandrene 2.0–14.0% + β-Phellandrene 10.0–24.0% + Limonene 7.5–15.0% + β-Pinene 1.3–4.3% + p-Cymene 0.5–2.4% + Furanocoumarins (total 0.2–2.0%): Xanthotoxin (8-methoxypsoralen, 8-MOP) + Bergapten (5-methoxypsoralen, 5-MOP) + Imperatorin + Angelicin (isobergapten) + Oxypeucedanin + Psoralen trace. Monoterpene-hydrocarbon dominant + furanocoumarin-phototoxic signature.
- Hazards: PHOTOTOXIC (root oil only); CYP3A4 mechanism-based inhibitor; drug interactions extensive. Contraindications: None absolute; phototoxicity avoidance + drug interaction caution. Max dermal 0.8% (T&Y — phototoxicity cap based on bergapten-equivalent furanocoumarin load). Oral caution: CYP3A4 substrates (statins, calcium-channel blockers, benzodiazepines, cyclosporine, many oncology drugs).
- Furanocoumarin-phototoxicity rail (FLAGSHIP — Apiaceae root): Unlike Ajowan (Apiaceae fruit, thymol, NO furanocoumarins), Angelica ROOT accumulates psoralen-derivatives that absorb UVA (320–400 nm) → excited-state species cross-link DNA pyrimidines → severe erythema + blistering + hyperpigmentation on UV-exposed skin. 12-hour UV avoidance post-topical use (like bergamot, lime-expressed). Angelica SEED oil (same species) has dramatically lower furanocoumarin content — NOT interchangeable at the same dermal cap.
- CYP3A4-mechanism-based-inhibition rail (CRITICAL — grapefruit-juice class): Bergapten + angelicin + imperatorin all irreversibly inactivate CYP3A4 (mechanism-based / suicide inhibition) — same mechanism as bergamottin + 6',7'-dihydroxybergamottin in grapefruit juice. Clinically equivalent to "grapefruit juice drug-interaction class" — affects ~50% of prescription drugs metabolized by CYP3A4. Oral aromatherapy use of angelica root is strongly cautioned in patients on statins (simvastatin, atorvastatin), calcium-channel blockers (felodipine, nifedipine), benzodiazepines (midazolam, triazolam), cyclosporine, tacrolimus, many oncology agents (imatinib, vincristine, paclitaxel), many antiarrhythmics. Even low oral doses may produce clinically meaningful AUC increases.
Tổng Quan
- Danh pháp khoa học
- Angelica archangelica L.
- Họ thực vật
- Apiaceae
- Bộ phận dùng
- —
- Phương pháp chiết xuất
- steam_distillation
- Màu sắc
- —
- Phân loại nốt hương
- Nốt Top/Middle
- Hương thơm
- —
- Chemotype / Cultivar
- —
Tình trạng tại Việt Nam
Xem chi tiết
Deep damp root, peppery-green wild undergrowth, cool dry coniferous breath, soft musky warmth like aged velvet, ancient and unhurried
Rễ cây trầm sâu ẩm đất, cay nhẹ thảo xanh hoang dã, hơi thở thông khô mát lạnh, musk ấm nhung mềm mại, cổ kính lặng yên
2–4 giờ
Tên gọi tại Việt Nam
Pha Chế & Hòa Hợp
Monoterpene hydrocarbon fraction (α-phellandrene, β-phellandrene, δ-3-carene per Kerrola 1994 and Chalchat 1991) may modulate GABA-A receptor activity, a class-typical CNS-depressant effect of monoterpene-rich Apiaceae oils; no angelica-specific human mechanistic data confirmed.
Ref: Tisserand & Young 2014, Ch.13 p.440; composition basis: Kerrola (1994); Chalchat (1991)
Phthalide constituents (ligustilide, 3-n-butylidenephthalide) shared with Apiaceae peers (celery, lovage) exert smooth-muscle spasmolytic activity on gastrointestinal tone; class-extrapolation from confirmed phthalide activity in peer species.
Ref: class-extrapolation from celery-seed / lovage-root (phthalide class); Tisserand & Young 2014, Ch.13 p.440
Monoterpene hydrocarbons (α- and β-phellandrene, limonene per Kerrola 1994; Chalchat 1991) promote mucociliary clearance and reduce mucous viscosity via surface-active effects, a class-level action across monoterpene-rich EOs.
Ref: Tisserand & Young 2014, Ch.13 p.440; composition basis: Kerrola (1994); Chalchat (1991)
Furanocoumarins (bergapten, psoralen, oxypeucedanin) act as mechanism-based irreversible inhibitors of CYP3A4, CYP1A2, CYP2A6, and CYP2B6; analogous to the grapefruit juice/bergamottin CYP3A4 effect (Bailey 1998), posing real drug-interaction risk at therapeutic doses.
Ref: Koenigs (1997); Bailey (1998) [paradigmatic CYP3A4 mechanism]; Ch.14 Furanocoumarin composite profile [via B216]
Traditional aromatherapy attribution shared across monoterpene-rich Apiaceae oils; proposed mechanism involves mild stimulation of lymphatic and venous circulation via topical application, though no controlled evidence confirms this for angelica root specifically.
Ref: Tisserand & Young 2014, Ch.13 p.440
β-Caryophyllene sesquiterpene, plausible in Apiaceae root chemistry, acts as selective CB2 receptor agonist modulating NF-κB inflammatory cascades; class-extrapolation — β-caryophyllene presence in this oil not confirmed by available Kerrola/Chalchat citations.
Ref: class-extrapolation from β-caryophyllene sesquiterpene class (e.g. copaiba, black pepper); Tisserand & Young 2014, Ch.13 p.440
AI-summary
No RCT-grade clinical evidence has been located for Angelica Root essential oil as a therapeutic agent. The most robust pharmacological data are in vitro: Koenigs (1997) demonstrated mechanism-based inhibition of CYP3A4, CYP1A2, CYP2A6, and CYP2B6 by angelica root furanocoumarins — a drug-interaction risk signal rather than a therapeutic claim. The photosensitization mechanism via bergapten/psoralen UV-A photoadduct formation is well-characterised (T&Y Ch.14 Bergapten profile). Opdyke (1975) confirmed non-sensitization in a 25-volunteer HRIPT at 4%, with high acute oral LD50 (rat 11 g/kg) and dermal LD50 >5 g/kg, establishing a safety baseline. Traditional aromatherapy use for digestive, respiratory, and nervous system support is documented in T&Y Ch.13 p.440 but lacks controlled human trial validation.
NarrativeTâm trạng: Grounding, Calming
Chakra
root
Ngũ hành
tho
| Phương pháp | Liều lượng | Ghi chú |
|---|---|---|
| Diffusion | 2–4 drops in 100 ml water (ultrasonic) or 2–3 drops neat (cold-air diffuser) | Preferred route — no phototoxicity risk via inhalation. Suitable for relaxation and respiratory support. Diffuse ≤30 min/session; ventilate room. Contraindicated around children. |
| Topical massage | 0.5–0.8% in carrier oil (3–5 drops per 30 ml carrier) | PHOTOTOXIC: avoid UV exposure on treated skin ≥12 h post-application, or apply only to covered areas. Hard cap 0.8%. Do not use on children. Avoid face/neck/décolletage before sun exposure. |
| Steam inhalation | 1–2 drops in bowl of hot water | Head-over-bowl, 5–10 min with eyes closed. No phototoxic risk via this route. Not suitable for children. |
| Bath | 2–3 drops pre-dispersed in 1 tsp unscented bath gel before adding to water | PHOTOTOXIC: avoid UV exposure on bathed skin ≥12 h. Pre-disperse in emulsifier to prevent neat-oil skin contact. Avoid in children. |
Dầu nền phù hợp
Kết hợp tốt với
Blend kinh điển
An Toàn
Giới hạn da tối đa
Xem chi tiết
Giới hạn IFRA
Xem chi tiết
Thai kỳ & Cho con bú
Giới hạn độ tuổi
Xem chi tiết
Bảo quản
Bảo quản nơi tối, mát